Skip to main content
Clinical Trials/NL-OMON29994
NL-OMON29994CompletedPhase 3

European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 - a protocol for non metastatic rhabdomyosarcoma - EpSSG-RMS-2005

Academisch Medisch Centrum0 sites98 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
98

Study Overview

Brief Summary

Trial is onging in other countries

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
2 to 17 (—)

Inclusion Criteria

  • Patients with pathologically confirmed rhabdomyosarcoma
  • No evidence of metastatic disease
  • Age 6 months - < 21 years
  • Included in the High Risk Group

Exclusion Criteria

  • Previously treated except initial surgery
  • Pre-existing illness preventing treatment
  • Previous malignant tumor

Investigators

Similar Trials